Attitudinal barriers to participation in oncology clinical trials: Factor analysis and correlates of barriers

European Journal of Cancer Care

Volumn 24, Issue 1, 2015, Pages 28-38

  Manne, S ^a   Kashy, D ^b   Albrecht, T ^c   Wong, Y N ^d   Lederman Flamm, A ^e   Benson, A B ^f   Miller, S M ^d   Fleisher, Linda ^g   Buzaglo, J ^h   Roach, N ⁱ   Katz, M ^j   Ross, E ^d   Collins, M ^k   Poole, D ^d   Raivitch, S ^d   Miller, D M ^l   Kinzy, T G ^l   Liu, T ^l   Meropol, N J ^l  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h Cancer Support Community   (United States)

ⁱ C3: Colorectal Cancer Coalition   (United States)

^j International Myeloma Foundation   (United States)

^k Infinity HealthCare Inc   (United States)

^l CASE WESTERN RESERVE UNIVERSITY   (United States)

more..

Author keywords

Attitudinal barriers; Decision support; Oncology clinical trials

Indexed keywords

AGED; ATTITUDE TO HEALTH; CLINICAL TRIAL (TOPIC); CROSS-SECTIONAL STUDY; DECISION MAKING; ECONOMICS; FACTOR ANALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASMS; PATIENT PARTICIPATION; PATIENT REFERRAL; PSYCHOLOGY; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

AGED; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; DECISION MAKING; FACTOR ANALYSIS, STATISTICAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT PARTICIPATION; REFERRAL AND CONSULTATION; SURVEYS AND QUESTIONNAIRES;

EID: 84919841449     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/ecc.12180     Document Type: Article

References (45)

1. Al-Refaie W.B., Vickers S.M., Zhong W., Parsons H., Rothenberger D. & Habermann E.B. (2011) Cancer trials versus the real world in the United States. Annals of Surgery 254, 438-442.
2. Avis N.E., Smith K.W., Link C.L., Hortobagyi G.N. & Rivera E. (2006) Factors associated with participation in breast cancer treatment clinical trials. Journal Clinical Oncology 24, 1860-1867.
3. Bevan E.G., Chee L.C., McGhee S.M. & McInnes G.T. (1993) Patients' attitudes to participation in clinical trials. British Journal of Clinical Pharmacology 35, 204-207.
4. Centers for Disease Control and Prevention (2012) Cancer statistics by cancer type. Available at: http://www.cdc.gov/cancer/dcpc/data/types.htm
5. Comis R.L., Miller J.D., Aldige C.R., Krebs L. & Stoval E. (2003) Public attitudes toward participation in cancer clinical trials. Journal of Clinical Oncology 21, 830-835.
6. Crosson K., Eisner E., Brown C. & Ter Maat J. (2001) Primary care physicians' attitudes, knowledge, and practices related to cancer clinical trials. Journal of Cancer Education 16, 188-192.
7. Daugherty C., Ratain M.J., Grochowski E., Stocking C., Kodish E., Mick R. & Siegler M. (1995) Perceptions of cancer patients and their physicians involved in phase I trials. Journal of Clinical Oncology 13, 1062-1072.
8. Eads J.R., Albrecht T.L., Egleston B., Buzaglo J.S., Cohen R.B., Fleisher L., Foster T., Katz M., Kinzy T., Manne S., Miller D.M., Miller S.M., Raivitch S., Roach N., Silver A. & Meropol N.J. (2011) Identification of barriers to clinical trials: the impact of education level. Journal of Clinical Oncology 29 (Suppl.), Abstr 6003.
9. Ellis P.M. (2000) Attitudes towards and participation in randomized clinical trials in oncology: a review of the literature. Annals of Oncology 11, 939-945.
10. Ellis P.M., Butow P.N., Simes R.J., Tattersall M.H. & Dunn S.M. (1999) Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists. Australian and New Zealand Journal of Surgery 69, 486-491.
11. Ellis P.M., Butow P.N., Tattersall M.H., Dunn S.M. & Houssami N. (2001) Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. Journal of Clinical Oncology 19, 3554-3561.
12. Fallowfield L.J., Jenkins V., Brennan C., Sawtell M., Moynihan C. & Souhami R.L. (1998) Attitudes of patients to randomised clinical trials of cancer therapy. European Journal of Cancer 34, 1554-1559.
13. Fleissig A., Jenkins V. & Fallowfield L. (2001) Results of an intervention study to improve communication about randomised clinical trials of cancer therapy. European Journal of Cancer 37, 322-331.
14. Ford M.E., Alford S.H., Britton D., McClary B. & Gordon H.S. (2007) Factors influencing perceptions of breast cancer genetic counseling among women in an urban health care system. Journal of Genetic Counseling 16, 735-753.
15. Grunfeld E., Zitzelsberger L., Coristine M. & Aspelund F. (2002) Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates. Cancer 95, 1577-1583.
16. Hu L. & Bentler P. (1999) Cutoff criteria for fit indices in covariance structure analyses. Structural Equation Model 6, 1-55.
17. Jacobsen P.B., Wells K.J., Meade C.D., Quinn G.P., Lee J.H., Fulp W.J., Gray J.E., Baz R.C., Springett G.M., Levine R.M., Markham M.J., Schreiber F.J., Cartwright T.H., Burke J.M., Siegel R.D., Malafa M.P. & Sullivan D. (2012) Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial. Journal of Clinical Oncology 30, 2516-2521.
18. Kaplan C.P., Napoles A.M., Dohan D., Hwang E.S., Melisko M., Nickleach D., Quinn J.A. & Haas J. (2013) Clinical trial discussion, referral, and recruitment: physician, patient, and system factors. Cancer Causes and Control 24, 979-988.
19. Kemeny M.M., Peterson B.L., Kornblith A.B., Muss H.B., Wheeler J., Levine E., Bartlett N., Fleming G. & Cohen H.J. (2003) Barriers to clinical trial participation by older women with breast cancer. Journal of Clinical Oncology 21, 2268-2275.
20. Kircher S.M., Benson A.B., III, Farber M. & Nimeiri H.S. (2012) Effect of the accountable care act of 2010 on clinical trials coverage. Journal of Clinical Oncology 30, 548-553.
21. Klabunde C.N., Springer B.C., Butler B., White M.S. & Atkins J. (1999) Factors influencing enrollment in clinical trials for cancer treatment. Southern Medical Journal 92, 1189-1193.
22. Lara P.N., Jr., Higdon R., Lim N., Kwan K., Tanaka M., Lau D.H., Wun T., Welborn J., Meyers F.J., Christensen S., O'Donnell R., Richman C., Scudder S.A., Tuscano J., Gandara D.R. & Lam K.S. (2001) Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. Journal of Clinical Oncology 19, 1728-1733.
23. Lara P.N., Jr., Paterniti D.A., Chiechi C., Turrell C., Morain C., Horan N., Montell L., Gonzalez J., Davis S., Umutyan A., Martel C.L., Gandara D.R., Wun T., Beckett L.A. & Chen M.S., Jr. (2005) Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. Journal of Clinical Oncology 23, 9282-9289.
24. Ling J., Rees E. & Hardy J. (2000) What influences participation in clinical trials in palliative care in a cancer centre? European Journal of Cancer 36, 621-626.
25. McCaskill-Stevens W., Pinto H., Marcus A.C., Comis R., Morgan R., Plomer K. & Schoentgen S. (1999) Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. Journal of Clinical Oncology 17, 1029-1039.
26. Melisko M.E., Hassin F., Metzroth L., Moore D.H., Brown B., Patel K., Rugo H.S. & Tripathy D. (2005) Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers. Clinical Breast Cancer 6, 45-54.
27. Meropol N.J., Weinfurt K.P., Burnett C.B., Balshem A., Benson A.B., III, Castel L., Corbett S., Diefenbach M., Gaskin D., Li Y., Manne S., Marshall J., Rowland J.H., Slater E., Sulmasy D.P., Van Echo D., Washington S. & Schulman K.A. (2003) Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. Journal of Clinical Oncology 21, 2589-2596.
28. Meropol N.J., Buzaglo J.S., Millard J., Damjanov N., Miller S.M., Ridgway C., Ross E.A., Sprandio J.D. & Watts P. (2007) Barriers to clinical trial participation as perceived by oncologists and patients. Journal of the National Comprehensive Cancer Network 5, 655-664.
29. Meropol N.J., Albrecht T., Micco E.S., Buzaglo J., Cohen R.B., Egleston B., Fleisher L., Foster T., Katz M., Manne S., Manning C., Miller D.M., Miller S.M., Raivitch S., Roach N. & Silver A. (2010) PRE-ACT: A web-based tool to provide preparatory education about clinical trials. Poster in NCI ASCO Cancer Trial Accrual Symposium: Science and Solutions: 29 April, Bethesda. Available at: https://accrualnet.cancer.gov/literature/preact_web_based_tool_provide_preparatory_education_about_clinical_trials#.UZ11EkpNXXI
30. Meropol N.J., Albrecht T.L., Wong Y.N., Benson A.B., Buzaglo J.S., Collins M., Eads J.R., Egleston B., Flamm A.L., Fleisher L., Katz M.S., Kinsey T.G., Manne S.L., Margevicius S., Miller D.M., Miller S.M., Poole D., Roach N., Ross E.A. & Schluchter M.D. (2013) Randomized Trial of a Web-based Intervention to Address Barriers to Clinical Trials. Oral presentation at the 2013 Annual American Society of Clinical Oncology Conference: 3 June, Chicago, IL.
31. Miller S.M., Fang C.Y., Manne S.L., Engstrom P.F. & Daly M.B. (1991) Decision making about prophylactic oophorectomy among at-risk women: psychological influences and implications. Gynecologic Oncology 75, 406-412.
32. Miller S.M., Shoda Y. & Hurley K. (1996) Applying cognitive-social theory to health-protective behavior: breast self-examination in cancer screening. Psychology Bulletin 119, 70-94.
33. Miller S.M., Rodoletz M., Mangan C.E., Schroeder C.M. & Sedlacek T.V. (1996) Applications of the monitoring process model to coping with severe long-term medical threats. Health Psychology 15, 216-225.
34. Miller S.M., Fleisher L., Roussi P., Buzaglo J.S., Schnoll R., Slater E., Raysor S. & Popa-Mabe M. (2005) Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service. Journal of Health Communication 10 (Suppl. 1), 119-136.
35. Mills E.J., Seely D., Rachlis B., Griffith L., Wu P., Wilson K., Ellis P. & Wright J.R. (2006) Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. The Lancet Oncology 7, 141-148.
36. Murthy V.H., Krumholz H.M. & Gross C.P. (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. Journal of the American Medical Association 291, 2720-2726.
37. Quinn G.P., Koskan A., Wells K.J., Gonzalez L.E., Meade C.D., Pozo C.L. & Jacobsen P.B. (2012) Cancer patients' fears related to clinical trial participation: a qualitative study. Journal of Cancer Education 27, 257-262.
38. Ratain M.J., Collyar D., Kamen B., Eisenhaurer E., Lawrence T.S., Runowicz C., Turner S. & Wade J.L., III (1997) Critical role of phase I clinical trials in cancer treatment. Journal of Clinical Oncology 15, 853-859.
39. Rivers D., August E.M., Sehovic I., Lee Green B. & Quinn G.P. (2013) A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemporary Clinical Trials 35, 13-32.
40. Simon S., Du W., Flaherty L., Philip P.A., Lorusso P., Miree C., Smith D. & Brown D.R. (2004) Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. Journal of Clinical Oncology 22, 2046-2052.
41. Sutherland H.J., da Cunha R., Lockwood G.A. & Till J.E. (1998) What attitudes and beliefs underlie patients' decisions about participating in chemotherapy trials? Medical Decision Making 18, 61-69.
42. Virani S., Burke L., Remick S.C. & Abraham J. (2011) Barriers to recruitment of rural patients in cancer clinical trials. Journal of Oncology Practitioners 7, 172-177.
43. Weinfurt K.P., Castel L.D., Li Y., Sulmasy D.P., Balshem A.M., Benson A.B., III, Burnett C.B., Gaskin D.J., Marshall J.L., Slater E.F., Schulman K.A. & Meropol N.J. (2003) The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer 98, 166-175.
44. Wright J.R., Crook D., Ellis P.M., Mings D. & Whelan T.J. (2002) Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associate. Cancer 95, 1584-1591.
45. Wright J.R., Whelan T.J., Schiff S., Dubois S., Crooks D., Haines P.T., DeRosa D., Roberts R.S., Gafni A., Pritchard K. & Levine M.N. (2004) Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. Journal of Clinical Oncology 22, 4312-4318.